Citadel Advisors
MESO

Citadel Advisors’s Mesoblast MESO Stock Holding History

Citadel Advisors’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.43M Sell
418,300
-49,800
-11% -$829K ﹤0.01% 3939
2025
Q4 		$8.44M Buy
468,100
+238,300
+104% +$4.1M ﹤0.01% 3480
2025
Q3 		$3.7M Buy
229,800
+88,450
+63% +$1.29M ﹤0.01% 4909
2025
Q2 		$1.54M Sell
141,350
-9,600
-6% -$108K ﹤0.01% 6203
2025
Q1 		$1.88M Sell
150,950
-137,900
-48% -$2.27M ﹤0.01% 5645
2024
Q4 		$5.72M Buy
288,850
+137,250
+91% +$1.52M ﹤0.01% 3746
2024
Q3 		$1.24M Buy
151,600
+51,350
+51% +$349K ﹤0.01% 6425
2024
Q2 		$683K Buy
100,250
+44,950
+81% +$307K ﹤0.01% 7405
2024
Q1 		$277K Sell
55,300
-126,950
-70% -$270K ﹤0.01% 9626
2023
Q4 		$401K Sell
182,250
-34,400
-16% -$82K ﹤0.01% 8565
2023
Q3 		$533K Buy
216,650
+28,850
+15% +$138K ﹤0.01% 7926
2023
Q2 		$1.47M Sell
187,800
-15,150
-7% -$108K ﹤0.01% 5711
2023
Q1 		$1.34M Sell
202,950
-25,100
-11% -$166K ﹤0.01% 6162
2022
Q4 		$1.33M Buy
228,050
+27,300
+14% +$171K ﹤0.01% 6271
2022
Q3 		$1.02M Buy
200,750
+47,150
+31% +$285K ﹤0.01% 6942
2022
Q2 		$682K Buy
153,600
+37,750
+33% +$260K ﹤0.01% 7933
2022
Q1 		$978K Sell
115,850
-4,050
-3% -$34.5K ﹤0.01% 7741
2021
Q4 		$1.15M Buy
119,900
+19,700
+20% +$229K ﹤0.01% 7599
2021
Q3 		$1.2M Sell
100,200
-5,350
-5% -$74.3K ﹤0.01% 7668
2021
Q2 		$1.58M Buy
105,550
+2,300
+2% +$36.1K ﹤0.01% 7197
2021
Q1 		$1.71M Buy
103,250
+2,950
+3% +$55.7K ﹤0.01% 6779
2020
Q4 		$1.7M Buy
100,300
+50,850
+103% +$1.25M ﹤0.01% 5703
2020
Q3 		$1.84M Buy
49,450
+43,050
+673% +$1.35M ﹤0.01% 4875
2020
Q2 		$146K Buy
+6,400
New +$137K ﹤0.01% 8762

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

Citadel Advisors's MESO Position: Q1 2026 in Review

Citadel Advisors reduced its Mesoblast (MESO) stake by 35% in Q1 2026, selling an estimated $756K and leaving 85,959 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #7027.

Citadel Advisors first reported a position in MESO in Q3 2018 and has held it in 19 quarters since. The position peaked at $6.08M in Q1 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Citadel Advisors held 85,959 shares of Mesoblast worth $1.32M as of Q1 2026.
  • Citadel Advisors sold 45,429 Mesoblast shares in Q1 2026, an estimated $756K.
  • Mesoblast made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7027 holding.
  • Citadel Advisors first reported a position in Mesoblast in Q3 2018 and has held it in 19 quarters since.
  • Citadel Advisors's Mesoblast position peaked at $6.08M in Q1 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.